Efficacy of alectinib in central nervous system metastases in crizotinib-resistant ALK -positive non–small-cell lung cancer: Comparison of RECIST 1.1 and RANO-HGG criteria

Title
Efficacy of alectinib in central nervous system metastases in crizotinib-resistant ALK -positive non–small-cell lung cancer: Comparison of RECIST 1.1 and RANO-HGG criteria
Authors
Keywords
Alectinib, CNS metastases, NSCLC, RANO-HGG, RECIST
Journal
EUROPEAN JOURNAL OF CANCER
Volume 82, Issue -, Pages 27-33
Publisher
Elsevier BV
Online
2017-07-10
DOI
10.1016/j.ejca.2017.05.019

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started